The story of GraalVM in early 2026: a project settling into a quarterly cadence, tightening its support matrix, and—thanks to Oracle—being very explicit about what it is no longer going to be.

CAMBRIDGE, England & DETROIT--(BUSINESS WIRE)--Cycle Group Holdings Limited (“Cycle”) is delighted to announce it has completed the acquisition of NASDAQ-listed Applied Therapeutics, Inc. (NASDAQ: ...

Applied Digital (NASDAQ: APLD) is emerging as an important player in the artificial intelligence (AI) infrastructure market, and this explains why investors bought its shares hand over fist in the ...

Applied Materials Inc. will pay $252.5 million to settle a US Commerce Department investigation into improper exports to China, ending a yearslong saga for the largest American supplier of chipmaking ...

Applied Materials AMAT-4.87%decrease; red down pointing triangle logged higher profit in the fiscal first quarter as artificial-intelligence computing demand soars. Profit jumped 70% to $2.03 billion, ...

Medical device company Applied Medical has been awarded $381,705,005 in damages after a federal jury in California found Medtronic liable for violations of federal and state antitrust laws. In ...

Inflammation comprises the detection and response to injury and pathogens, the accumulation and intervention of cells that eliminate invading microorganisms and infected host cells, and the repair of ...

This profile has not been claimed by the company. See reviews below to learn more or submit your own review. How do I know I can trust these reviews about Matrix Absence Management? How do I know I ...

45,987 shares were sold in a direct open-market transaction, totaling ~$1.8 million at a reported price of $38.57 per share on Jan. 29, 2026. The transaction represented 10.59% of Chuck Hastings' ...

Applied Therapeutics, Inc. (NASDAQ:APLT) announced Tuesday the completion of its merger with Cycle Group Holdings Limited, resulting in Applied Therapeutics becoming an indirect wholly owned ...

The healthcare company Syncona Limited has announced its newly established portfolio company is to acquire all outstanding shares of Applied Genetic Technologies Corporation (AGTC), a clinical-stage ...